- Home
- ATXS vs BMRC Comparison
ATXS vs BMRC Comparison
Compare ATXS & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- BMRC
- Stock Information
- Founded
- ATXS 2008
- BMRC 1989
- Country
- ATXS United States
- BMRC United States
- Employees
- ATXS N/A
- BMRC N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- BMRC Major Banks
- Sector
- ATXS Health Care
- BMRC Finance
- Exchange
- ATXS Nasdaq
- BMRC Nasdaq
- Market Cap
- ATXS 401.2M
- BMRC 416.8M
- IPO Year
- ATXS 2015
- BMRC N/A
- Fundamental
- Price
- ATXS $6.65
- BMRC $23.78
- Analyst Decision
- ATXS Strong Buy
- BMRC Buy
- Analyst Count
- ATXS 7
- BMRC 4
- Target Price
- ATXS $32.43
- BMRC $25.50
- AVG Volume (30 Days)
- ATXS 304.1K
- BMRC 117.4K
- Earning Date
- ATXS 08-11-2025
- BMRC 07-28-2025
- Dividend Yield
- ATXS N/A
- BMRC 4.25%
- EPS Growth
- ATXS N/A
- BMRC N/A
- EPS
- ATXS N/A
- BMRC N/A
- Revenue
- ATXS N/A
- BMRC $70,630,000.00
- Revenue This Year
- ATXS N/A
- BMRC $60.39
- Revenue Next Year
- ATXS N/A
- BMRC $10.56
- P/E Ratio
- ATXS N/A
- BMRC N/A
- Revenue Growth
- ATXS N/A
- BMRC N/A
- 52 Week Low
- ATXS $3.56
- BMRC $16.97
- 52 Week High
- ATXS $12.92
- BMRC $27.11
- Technical
- Relative Strength Index (RSI)
- ATXS 60.88
- BMRC 45.68
- Support Level
- ATXS $5.94
- BMRC $24.57
- Resistance Level
- ATXS $6.49
- BMRC $25.40
- Average True Range (ATR)
- ATXS 0.34
- BMRC 0.62
- MACD
- ATXS -0.00
- BMRC -0.28
- Stochastic Oscillator
- ATXS 74.74
- BMRC 12.15
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.